From Weight Loss Drugs to Cancer Vaccines: A Contrarian Bet on Two Biotech Stocks

Life Science

Marijuana Legalization: A State-by-State Overview

Cannabis

Novo Nordisk Regains Spotlight with New Oral Formulation, Stock May Have 40% Upside Potential

Life Science

FDA Delays Lilly’s Weight-Loss Pill: Is the Stock Still a Buy for 2026?

Life Science

Two Healthcare Companies Are Planning for the Long Term with AI 

Life Science

This International ETF Outperformed the S&P 500

Life Science, Technology

Prospects for a Strong Rebound by Two Healthcare Giants: Zoetis and Regeneron Pharmaceuticals 

Life Science

Decoding the Gene Editing Sector and Focusing on Progress and Investment Perspectives of Three Leading Companies 

Life Science

Can Viking Therapeutics Make a Turnaround This Year?

Life Science

Why Intuitive Surgical Could Still Lead the Robotic Surgery Market in 5 Years

Life Science

Massive Upside Potential: Two Canadian Growth Stocks for Risk-Tolerant Investors

Life Science, Precious Metals

As TSX Hits Record Highs, This Healthcare Tech Stock Sits in a “Value Gap”

Life Science, Technology

GSK to Acquire RAPT Therapeutics for $2.2 Billion, Bolstering Food Allergy Pipeline

Life Science

The Long-Term Investment Value of Eli Lilly, AbbVie, and Intuitive Surgical

Life Science

French Biotech Abivax Soared 1,740% Last Year. Can the Rally Continue?

Life Science